NCATS Seeks Proposals for Pfizer’s Centers for Therapeutic Innovation (CTI) Program

Pre-Proposal Portal Opens May 2

NCATS is seeking pre-proposals from NIH intramural researchers interested in collaboration opportunities with Pfizer’s Centers for Therapeutic Innovation (CTI).

Pfizer’s CTI pairs leading researchers with Pfizer resources to help scientists pursue scientific and medical advances through joint therapeutic development. The CTI model is the first NIH-wide biologics initiative with a pharmaceutical partner that NCATS coordinates on behalf of all NIH intramural researchers. Goals include identifying biologic compounds with activity in a pathway or target of interest to an NIH intramural researcher and to Pfizer and moving the compounds into the clinic to test them.

The first call for pre-proposals is due to the technology transfer office of the investigator’s NIH Institute or Center by June 17, 2016. Technology transfer staff must submit the pre-proposals by June 24, 2016, via the Pfizer CTI submission portal at https://proposalportal.pfizercti.com/.